The vaccine stock benefited from two positive developments. Key Points A Wall Street analyst raised his price target for Moderna. A top European official also stated that a recommendation on ...
网页链接The vaccine stock benefited from two positive developments. Key Points A Wall Street analyst raised his price target for Moderna. A top European official also stated that a recommendation on ...
网页链接
精彩评论